This study showed that the vast majority of GBM harbor alterations in three core signaling pathways: receptor tyrosine kinase (RTK)/Ras/phosphoinositide 3-kinase (PI3K), p53 and RB pathways [42]. The gene discussed is TP53; the disease is glioblastoma.